Telefon:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@antikoerper-online.de

EBV Antikörper

Dieses Anti-EBV-Antikörper ist ein Schaf Polyklonal-Antikörper zur Detektion von EBV in WB. Geeignet für Epstein-Barr Virus (EBV). Dieses Primary Antibody wurde in 7+ Publikationen zitiert.
Produktnummer ABIN264912

Kurzübersicht für EBV Antikörper (ABIN264912)

Target

EBV (Epstein-Barr Virus (EBV))

Reaktivität

  • 67
  • 6
Epstein-Barr Virus (EBV)

Wirt

  • 67
  • 3
  • 2
  • 1
Schaf

Klonalität

  • 69
  • 3
Polyklonal

Konjugat

  • 31
  • 5
  • 5
  • 5
  • 5
  • 5
  • 5
  • 5
  • 5
  • 2
Dieser EBV Antikörper ist unkonjugiert

Applikation

  • 56
  • 50
  • 48
  • 38
  • 13
  • 8
  • 5
  • 3
  • 2
  • 1
  • 1
Western Blotting (WB)
  • Aufreinigung

    Purified

    Isotyp

    IgG
  • Applikationshinweise

    Western Blot: 0.25-1.00 μg/mL.
    Other applications not tested.
    Optimal dilutions are dependent on conditions and should be determined by the user.

    Beschränkungen

    Nur für Forschungszwecke einsetzbar
  • Buffer

    PBS, 0.08 % Sodium Azide

    Konservierungsmittel

    Sodium azide

    Vorsichtsmaßnahmen

    This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

    Handhabung

    Avoid repeated freezing and thawing.

    Lagerung

    -20 °C
  • Anderton, Yee, Smith, Crook, White, Allday: "Two Epstein-Barr virus (EBV) oncoproteins cooperate to repress expression of the proapoptotic tumour-suppressor Bim: clues to the pathogenesis of Burkitt's lymphoma." in: Oncogene, Vol. 27, Issue 4, pp. 421-33, (2008) (PubMed).

    Jiménez-Ramírez, Brooks, Forshell, Yakimchuk, Zhao, Fulgham, Sample: "Epstein-Barr virus EBNA-3C is targeted to and regulates expression from the bidirectional LMP-1/2B promoter." in: Journal of virology, Vol. 80, Issue 22, pp. 11200-8, (2006) (PubMed).

    Yuan, Cahir-McFarland, Zhao, Kieff: "Virus and cell RNAs expressed during Epstein-Barr virus replication." in: Journal of virology, Vol. 80, Issue 5, pp. 2548-65, (2006) (PubMed).

    Hong, Gulley, Feng, Delecluse, Holley-Guthrie, Kenney: "Epstein-Barr virus lytic infection contributes to lymphoproliferative disease in a SCID mouse model." in: Journal of virology, Vol. 79, Issue 22, pp. 13993-4003, (2005) (PubMed).

    Maruo, Johannsen, Illanes, Cooper, Kieff: "Epstein-Barr Virus nuclear protein EBNA3A is critical for maintaining lymphoblastoid cell line growth." in: Journal of virology, Vol. 77, Issue 19, pp. 10437-47, (2003) (PubMed).

    Rosendorff, Illanes, David, Lin, Kieff, Johannsen: "EBNA3C coactivation with EBNA2 requires a SUMO homology domain." in: Journal of virology, Vol. 78, Issue 1, pp. 367-77, (2003) (PubMed).

    ONions, Allday: "Epstein-Barr virus can inhibit genotoxin-induced G1 arrest downstream of p53 by preventing the inactivation of CDK2." in: Oncogene, Vol. 22, Issue 46, pp. 7181-91, (2003) (PubMed).

  • Target

    EBV (Epstein-Barr Virus (EBV))

    Andere Bezeichnung

    Epstein Barr Virus / EBV

    Substanzklasse

    Virus

    Hintergrund

    EBNA-3A is a latent viral nuclear protein expressed in EBV transformed lymphoblastic cell lines. It is also found in some immunoblastic lymphomas in vivo. This viral nuclear protein is essential for EBV mediated transformation of B lymphocytes. The EBNA-3A functions as a transcriptional regulator though the target genes are currently unknown. Plays an essential role for activation and immortalization of human B-cells. Represses transcription of viral promoters TP1 and Cp through interaction with host RBPJ, and inhibits EBNA2-mediated activation of these promoters. Since Cp is the promoter for all EBNA mRNAs, EBNA3A probably contributes to a negative autoregulatory control loop.Synonyms: HHV-4, HHV4

    Molekulargewicht

    102.4 kDa
Sie sind hier:
Chat with us!